Zymeworks announces executive changes

Mark Hollywood has been promoted to Executive Vice President and COO with expanded responsibilities beyond his current leadership of Technology and Manufacturing Operations, Quality, and Alliance/Program Management. Dr. Sabeen Mekan has been promoted to Senior Vice President and Chief Medical Officer effective February 1, with overall responsibility for clinical development, regulatory affairs, pharmacovigilance/patient safety, and clinical operations. Dr. Jeff Smith, current CMO, will be retiring effective January 31, while continuing to provide services as an adviser for a transitional time period. Leone Patterson, Chief Financial and Business Officer and Daniel Dex, General Counsel, will both be departing from their roles at Zymeworks (ZYME) during the first quarter of 2026. The company has commenced a comprehensive search for a permanent CFO with the experience required to support the company’s next phase of development. Galbraith has assumed the role of Acting CFO until a replacement is secured.